oxybutynin and losartan potassium

oxybutynin has been researched along with losartan potassium in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Cappola, AR; Cattabiani, C; Ceda, GP; Ferrucci, L; Lauretani, F; Longo, D; Luci, M; Maggio, M; Masoni, S; Milaneschi, Y; Peachey, H; Snyder, PJ; Valenti, G; Vignali, A; Volpi, R	1

Trials

1 trial(s) available for oxybutynin and losartan potassium

Article	Year
Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men. Andrology, 2013, Volume: 1, Issue:1 Topics: Administration, Cutaneous; Aged; Biomarkers; Double-Blind Method; Erythropoietin; Hematopoiesis; Hemoglobins; Hormone Replacement Therapy; Humans; Male; Philadelphia; Testosterone; Time Factors; Transdermal Patch; Treatment Outcome; Up-Regulation	2013

Article

Year

Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men.

Andrology, 2013, Volume: 1, Issue:1

Topics: Administration, Cutaneous; Aged; Biomarkers; Double-Blind Method; Erythropoietin; Hematopoiesis; Hemoglobins; Hormone Replacement Therapy; Humans; Male; Philadelphia; Testosterone; Time Factors; Transdermal Patch; Treatment Outcome; Up-Regulation

2013

Other Studies

2 other study(ies) available for oxybutynin and losartan potassium

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Recent changes to FDA-approved labeling. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004, Sep-01, Volume: 61, Issue:17 Topics: Acetamides; Aminoquinolines; Atazanavir Sulfate; Atorvastatin; Botulinum Toxins, Type A; Dosage Forms; Drug Labeling; Epoetin Alfa; Erythropoietin; Heptanoic Acids; Humans; Imiquimod; Insulin; Insulin Lispro; Mandelic Acids; Oligopeptides; Oseltamivir; Pyridines; Pyrroles; Recombinant Proteins; United States; United States Food and Drug Administration	2004

Article

Year

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013

Recent changes to FDA-approved labeling.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004, Sep-01, Volume: 61, Issue:17

Topics: Acetamides; Aminoquinolines; Atazanavir Sulfate; Atorvastatin; Botulinum Toxins, Type A; Dosage Forms; Drug Labeling; Epoetin Alfa; Erythropoietin; Heptanoic Acids; Humans; Imiquimod; Insulin; Insulin Lispro; Mandelic Acids; Oligopeptides; Oseltamivir; Pyridines; Pyrroles; Recombinant Proteins; United States; United States Food and Drug Administration

2004